Skip to main content
OLYMPUS CORPORATION logo

OLYMPUS CORPORATION — Investor Relations & Filings

Ticker · 7733 ISIN · JP3201200007 LEI · 5299000Y52IFDI1I2A21 T Manufacturing
Open in API
Filings indexed 102 across all filing types
Latest filing 2024-06-20 Governance Information
Country JP Japan
Listing T 7733

About OLYMPUS CORPORATION

https://www.olympus-global.com/

Olympus Corporation is a global medical technology (medtech) company focused on making people's lives healthier, safer, and more fulfilling. The company develops, manufactures, and commercializes innovative solutions for the medical and healthcare sectors, specializing in early detection, diagnosis, and minimally invasive treatment. Its core product portfolio includes medical endoscopes, endotherapy devices, and therapeutic energy devices. These technologies are applied across various medical specialties such as gastroenterology, urology, gynecology, and general surgery. Leveraging its expertise in optical and digital precision technology, Olympus provides comprehensive solutions that also encompass advanced video imaging systems and system integration services for healthcare facilities.

Recent filings

Filing Released Lang Actions
内部統制報告書－第156期(2023/04/01－2024/03/31)
Governance Information Classification · 100% confidence The document is titled "内部統制報告書" (Internal Control Report) and explicitly states its basis in Article 24-4-4, Paragraph 1 of the Financial Instruments and Exchange Act ("金融商品取引法第24条の４の４第１項"). It details the scope, criteria, and procedures for evaluating internal controls over financial reporting as of the fiscal year-end (March 31, 2024), concluding that the internal controls are effective. This structure and content directly correspond to the requirements for an Audit Report/Information filing, specifically concerning internal controls, which aligns best with the 'Audit Report / Information (AR)' definition, as it is a formal report on internal control effectiveness, distinct from a full Annual Report (10-K) or a simple Earnings Release (ER).
2024-06-20 Japanese
確認書
Regulatory Filings Classification · 100% confidence The document is titled '確認書' (Confirmation Letter) and explicitly states it is submitted under Article 24-4-2, Paragraph 1 of the Financial Instruments and Exchange Act. It serves as an officer certification confirming the accuracy of the company's Annual Securities Report (有価証券報告書). According to the 'CERTIFICATION RULE', documents that are primarily officer certifications or attestations should be classified as Regulatory Filings (RNS), even if they reference a specific report type. FY 2024
2024-06-20 Japanese
有価証券報告書－第156期(2023/04/01－2024/03/31)
Annual Report Classification · 100% confidence The document is a Japanese 'Yuka Shoken Hokokusho' (Securities Report), which is the Japanese equivalent of the US 10-K. It contains the official annual financial reporting for Olympus Corporation for the fiscal year ending March 31, 2024, as required by the Financial Instruments and Exchange Act. It is a comprehensive annual filing, not an announcement or a summary. FY 2024
2024-06-20 Japanese
有価証券届出書（参照方式）
Capital/Financing Update Classification · 98% confidence The document is titled "有価証券届出書" (Securities Registration Statement) on the cover page, submitted to the Kanto Local Finance Bureau on May 13, 2024. It details the proposed issuance of common stock (189,070 shares) related to the company's RSU and PSU stock compensation plans. In the Japanese regulatory framework, a document filed to register the offering or sale of securities, especially one detailing the specifics of the offering price, method, and use of proceeds, corresponds to a registration statement. While the US equivalent is often Form S-1 or F-1, among the provided codes, the closest fit for a comprehensive registration document detailing a securities offering (even if it's a self-offering for compensation) is often categorized broadly or related to capital changes. However, the core function described here is the formal registration of a securities offering/issuance to the regulatory body (Kanto Finance Bureau). This type of filing, which registers the offering of securities for sale/allotment, is generally classified as a registration statement. Given the options, and recognizing that this is a formal filing detailing the terms of a securities offering/allotment (which is a form of capital/financing activity, but specifically a registration filing), the most appropriate general category for a formal registration document that isn't a periodic report (10-K, IR) or a specific announcement (ER, DIV) is often related to capital changes or a general regulatory filing. Since it explicitly registers the offering of securities (募集有価証券), it is a registration statement. In the context of the provided codes, 'CAP' (Capital/Financing Update) is plausible, but the document's structure and title strongly suggest a formal registration filing required under the Financial Instruments and Exchange Act. Since there is no explicit 'Registration Statement' code, and it details a capital change (share issuance), 'CAP' is a possibility, but 'RPA' (Report Publication Announcement) or 'RNS' (Regulatory Filings) are for announcements *about* reports. Given the detailed nature of the offering terms, it is a primary filing. In many contexts, a registration statement for an offering is distinct. Based on the provided list, and noting that this is a formal filing detailing the terms of a share issuance/allotment, it is most closely related to capital structure changes. However, if we interpret '有価証券届出書' as a mandatory regulatory filing that doesn't fit other specific categories like 10-K or IR, 'RNS' (Regulatory Filings - fallback) might be considered. Given the content is about the mechanics of issuing shares for compensation, 'CAP' (Capital/Financing Update) is a strong candidate, but '有価証券届出書' is a specific type of registration document. Since the document is a full registration statement detailing the offering terms, and not just a brief announcement of a capital event, it is a substantial regulatory filing. If we must choose the best fit from the list, and recognizing that this is a filing related to the issuance of new shares (a capital event), 'CAP' is reasonable, but 'RNS' is the catch-all for formal regulatory documents. Given the document is a formal registration statement (有価証券届出書), which is a core regulatory disclosure, 'RNS' (Regulatory Filings) is the safest classification when a specific registration code is missing, as it is a mandatory filing under the Financial Instruments and Exchange Act. I will lean towards RNS as the comprehensive regulatory filing type.
2024-05-13 Japanese
発行登録書（株券､社債券等）
Capital/Financing Update Classification · 98% confidence The document is titled "発行登録書（株券、社債券等）" which translates to "Shelf Registration Statement (Stocks, Bonds, etc.)". The filing explicitly states the document type as "発行登録書" (Shelf Registration Statement) and is submitted to the Kanto Local Finance Bureau ("関東財務局長"). It details the planned issuance of corporate bonds ("社債") over a two-year period, including the maximum planned issuance amount ("発行予定額 200,000百万円"). This type of filing, related to the registration of securities for future issuance, aligns best with the category for financing activities or capital structure changes, which is 'Capital/Financing Update' (CAP). It is not a full annual report (10-K), an interim report (IR), or a simple announcement of a report (RPA/RNS), as it contains substantive details about the planned financing structure.
2024-04-15 Japanese
確認書
Report Publication Announcement Classification · 100% confidence The document text is titled "第３四半期報告書" (Third Quarter Report) and explicitly states that the Representative Director and CEO confirms the appropriateness of the contents of the 'Quarterly Report for the Third Quarter of the Fiscal Year Ending March 2024 (October 1, 2023, to December 31, 2023)'. This content structure, focusing on the confirmation of a quarterly report's accuracy under financial instruments law, strongly indicates a comprehensive quarterly financial filing. This aligns directly with the definition of an Interim / Quarterly Report (IR), which covers financial reports for periods shorter than a year. Although it contains a confirmation statement, the core subject is the quarterly financial report itself, not just an announcement of its publication.
2024-02-14 Japanese

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.